1. Home
  2. EDSA vs CLRO Comparison

EDSA vs CLRO Comparison

Compare EDSA & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • CLRO
  • Stock Information
  • Founded
  • EDSA 2015
  • CLRO 1983
  • Country
  • EDSA Canada
  • CLRO United States
  • Employees
  • EDSA N/A
  • CLRO N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • CLRO Radio And Television Broadcasting And Communications Equipment
  • Sector
  • EDSA Health Care
  • CLRO Technology
  • Exchange
  • EDSA Nasdaq
  • CLRO Nasdaq
  • Market Cap
  • EDSA 13.8M
  • CLRO 12.5M
  • IPO Year
  • EDSA N/A
  • CLRO N/A
  • Fundamental
  • Price
  • EDSA $2.18
  • CLRO $9.31
  • Analyst Decision
  • EDSA Strong Buy
  • CLRO
  • Analyst Count
  • EDSA 2
  • CLRO 0
  • Target Price
  • EDSA $13.00
  • CLRO N/A
  • AVG Volume (30 Days)
  • EDSA 22.9K
  • CLRO 2.1M
  • Earning Date
  • EDSA 08-08-2025
  • CLRO 08-14-2025
  • Dividend Yield
  • EDSA N/A
  • CLRO N/A
  • EPS Growth
  • EDSA N/A
  • CLRO N/A
  • EPS
  • EDSA N/A
  • CLRO N/A
  • Revenue
  • EDSA N/A
  • CLRO $10,077,000.00
  • Revenue This Year
  • EDSA N/A
  • CLRO N/A
  • Revenue Next Year
  • EDSA N/A
  • CLRO N/A
  • P/E Ratio
  • EDSA N/A
  • CLRO N/A
  • Revenue Growth
  • EDSA N/A
  • CLRO N/A
  • 52 Week Low
  • EDSA $1.55
  • CLRO $4.35
  • 52 Week High
  • EDSA $5.59
  • CLRO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 60.86
  • CLRO 55.63
  • Support Level
  • EDSA $1.89
  • CLRO $9.75
  • Resistance Level
  • EDSA $2.23
  • CLRO $12.25
  • Average True Range (ATR)
  • EDSA 0.11
  • CLRO 1.24
  • MACD
  • EDSA 0.02
  • CLRO 0.21
  • Stochastic Oscillator
  • EDSA 85.29
  • CLRO 40.56

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About CLRO ClearOne Inc. (DE)

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.

Share on Social Networks: